This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Artificial intelligence (AI) is rapidly transforming the healthcare industry, with its ability to process and analyze vast amounts of data. However, not all patients respond well to immunotherapy and it can have significant sideeffects. Even just a year ago, we couldn’t fathom a cure for cancer. Now, we can.
Yet, the healthcare experience often begins with a decidedly analog ritual: The dreaded patient intake form. For too long, the administrative side of healthcare has lagged behind its clinical advancements. In this blog, well explore how digital patient intake can revolutionize healthcare efficiency, one click (or tap) at a time.
The Medicines and Healthcare products Regulatory Agency (MHRA) aims to launch a pilot genetic biobank that will gather patient data to associate drug-related adverse events to their genetic makeup. According to the press release, the MHRA will be the first drug safety regulator in the world to pilot such a biobank.
Within the EU, patient information leaflets (PILs) are not merely a regulatory requirement but a cornerstone of patient safety. They detail the medication’s intended use, proper administration, potential sideeffects and precautions. percent as EU average with some Member States as high as 25 percent).
Early findings have shown that HCPs in urban settings demonstrated a strong preference for data-driven decision-making and access to detailed information, such as comparative efficacy, safety data, and long-term outcomes. Rural-based HCPs expressed a strong need for treatments with manageable sideeffects and simplified dosing regimens.
The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has approved an updated version of Moderna’s COVID-19 vaccine, Spikevax, that targets two coronavirus variants as a booster. The regulator confirmed that the vaccine meets its standards of safety, quality and effectiveness.
Imagine having a tool that allows you to target specific audiences actively searching for healthcare solutions, like branded medications or treatment options. In a world where patients and healthcare professionals (HCPs) search for drug information online, PPC lets you stay top-of-mind. PPC does just that. Simple: visibility.
It has been conditionally authorised by the UK Medicines and Healthcare products Regulatory Agency (MHRA) as a gene-editing therapy for certain patients 12 years old and over with sickle-cell disease and transfusion-dependent β-thalassemia. Sideeffects from treatment were similar to those associated with autologous stem cell transplants.
It has been granted marketing authorisation by the Medicines and Healthcare Products Regulatory Agency (MHRA) in Great Britain. The most common sideeffects observed were initial insomnia, irritability and dyskinesia. The product, produced by biopharma company PTC Therapeutics, is approved for patients 18 months and over.
With millions of healthcare professionals (HCPs) and patients turning to Google for medical information, paid search ads present a huge opportunity for pharma brands to boost engagement and conversions. Higher Engagement: Paid search results get twice the clicks of organic results in the healthcare industry.
Introduction Reaching healthcare professionals (HCPs) in the pharmaceutical industry has become increasingly challenging due to strict regulations, evolving digital landscapes, and the growing demand for personalized content. This makes PPC a cost-effective strategy for reaching niche healthcare audiences.
The week 16 data of lebrikizumab […] points towards a drug with robust efficacy with hardly any safety trade-offs. Minor sideeffects to long-term maintenance balance. Any clinical study seeks to achieve maximum results efficacy with minimal occurrence of sideeffects. However, sideeffects do happen.
In today’s competitive healthcare landscape, PPC campaigns (Pay-Per-Click advertising) have emerged as a critical lever for pharma marketers aiming to deliver timely, targeted, and measurable impact. Todays digitally savvy patients and healthcare professionals expect real-time answers and seamless online experiences.
The UK Medicines and Healthcare products Regulatory Agency (MHRA) has granted conditional authorisation for Moderna ’s Covid-19 booster vaccine, mRNA-1273.214 (Spikevax Bivalent Original/Omicron), for use in adults aged 18 years and above. In addition, no serious safety concerns linked to the vaccine were observed.
On 29 November, the UK’s Medicines and Healthcare products Regulatory Agency (MHRA) warned of some new and potentially serious eye-related sideeffects associated with Dupixent, an interleukin (IL)-4/13 inhibitor drug used in the treatment of numerous allergic indications such as atopic dermatitis, asthma and nasal polyps.
Pharmaceutical marketing is a critical aspect of the industry, as it helps in spreading awareness about the benefits and potential sideeffects of different drugs. In recent years, digital marketing has become an increasingly important tool for pharmaceutical companies to reach patients and healthcare providers.
Traditional outreach methods are no longer enough to engage healthcare professionals (HCPs) and patients in a digital-first world. A single misstepsuch as targeting the wrong audience or omitting safety disclaimers can lead to regulatory violations and ad disapprovals. For any health issues, always consult a healthcare professional.
But the role of AI in healthcare will go beyond this. healthcare, with its 17% share of GDP, is “the most disruptable industry in the world,” and “the first big carcass that AI is going to start to feed on.” It provides guidance and acts as a safety net for prescribers. And there’s more to come. AI isn’t coming for your job.
Consequently, there’s a strong collective yearning for experiences that evoke the desire to savor and provoke wonder, discovery, and fascination, while feeling rooted in our shared humanity — offering safety and healing. In a category like healthcare, wellness is often depicted superficially, with a breadth of an inch and depth of a mile.
While data from the Phase III trial is not yet available, the Phase IIb CONDUCT trial (NCT03178669) assessed the efficacy and safety of cobitolimod in patients with moderately to severely active UC and demonstrated promising results and a strong safety profile.
The main objective was to evaluate the efficacy and safety of MBK-01 compared to fidaxomicin, providing significant insights into the potential of MBK-01 as a treatment for primary or recurrent CDI and contributing to the advancement of microbiome-based therapies. The study included 92 adult patients with confirmed CDI.
Non-invasive healthcare products refer to medical devices or technologies that do not require puncturing the skin or entering the body in any way to diagnose, treat, or monitor a health condition. They are designed to be safe and comfortable for patients, and typically have minimal sideeffects.
Healthcare is notoriously conservative in its adoption of technology. With the sudden physical distance between patients and healthcare facilities imposed by the lockdown, providers proved they could transition to virtual care instantly. Now with the appropriate safety measures in place, they are urging patients to come back.
There have been great strides made in genomics to refine tools that determine the safest, most effective course of treatments for patients across a number of disease states. This means that hyper-metabolisers would need their dosage to be increased to achieve the desired effect.
Selling to private practice doctors is different than selling to healthcare organizations. To convince doctors that a product is worth recommending to their patients you need to have strong evidence supporting both its effectiveness and its safety.
This includes in-depth knowledge of the science behind the products, as well as their indications, contraindications, and potential sideeffects. This helps me to be able to answer any question or concern a healthcare provider may have about the product. But product knowledge is not the only important aspect of my job.
It also underscores the need for patients to communicate openly with their healthcare providers about any health concerns or issues they may have. This includes potential sideeffects or adverse reactions to medications. This is before a drug can be approved for public use.
These treatments at times come with a long list of sideeffects, leaving many patients in search of an effective long-term solution. For some patients with PTSD, psychotherapy may not be an effective option, they may find talking about their traumatic experience stress inducing, untherapeutic or ineffective.
Additionally, EURneffy could alleviate the risk of accidental needle-related sideeffects (such as injection into the blood vessel and hand) 3 and it has the attributes of being smaller in size, has better temperature sensitivity, and is less complex to use compared to needle-based injectors. .”
In theory, this will allow for highly tailored, personalized therapy plans with superior efficacy and minimal sideeffects. To avoid compliance issues , it is essential to keep up with new regulatory changes, including updated reporting guidelines and safety requirements.
According to the 2021 Accenture Healthcare Experience Survey, 52% of patients say having emotional support is important to having a positive healthcare experience. Housing, access to food and transportation, as well as the ability to pay for healthcare and medicine are just a few economic barriers to medical adherence.
One reason for this growth is an increasing demand for personalized healthcare technologies as patients look for advances in how healthcare is delivered following the pandemic. NovaXS is on a mission to simplify the medication self-administration process and improve remote healthcare adherence. billion in 2030 at a CAGR of 9.2%.
healthcare system but we haven’t seen widespread acceptance by doctors and patients. AI also helps drive brands’ strategies on which message should be seen in which channel—for example, information on clinical efficacy, safety, formulary status, or interchangeability designation—and when that message will be most effective.
Pegozafermin also has a favourable safety and tolerability profile, with few gastrointestinal (GI) sideeffects. The ability to reverse disease progression, resulting in fewer liver transplants and treatments, could save the healthcare system billions annually. It is becoming the leading cause for liver transplants.
Its about reaching healthcare professionals (HCPs), patients, and stakeholders through targeted, value-driven messaging. Real-Time Feedback: Use platforms like Veeva CRM to gauge the effectiveness of your campaigns. Highlight unique selling points (USPs) like safety profiles, ease of use, or long-term outcomes.
We were drilled on the science behind our medications, their benefits, potential sideeffects, and the competitive landscape. We were the bridge between the pharmaceutical companies and the healthcare providers, and our credibility depended on our knowledge and communication skills.
A step-by step guide on the benefits, processes, and key considerations involved in the Healthcare Technology Assessment (HTA) Early Scientific Advice (ESA) consultation as part of planning the holistic evidence generation to support the design of an asset. In recent years, the biopharma market has become progressively complex.
In the competitive landscape of the pharmaceutical industry, effective marketing strategies are crucial for brand success. Pharmaceutical marketing is not just about reaching healthcare professionals and patients; it involves a complex interplay of understanding market dynamics, regulatory compliance, and leveraging digital platforms.
Their role involves presenting complex drug information to healthcare professionals who rely on this knowledge to make informed prescribing decisions. 3 Together, these processes determine the drugs concentration in the bloodstream and tissues over time, directly impacting its effectiveness and safety.
But before pharmaceutical companies can go to market with a breakthrough drug, they need to ensure safety and efficacy through clinical trials. Pharma companies need tools like AI that can reliably improve this percentage without jeopardizing safety. The need for new medical treatments and drugs has never been greater.
Speciality pharmacies play a crucial role in medication dosing, disease and sideeffects management, and patient care. The expert services rendered by them help in improving patient outcomes, minimising costs of the healthcare system, improving medicinal adherence and persistency and saving clinicians’ time.
Real-world data (RWD) is a critical tool for advancing healthcare innovation, improving health outcomes, lowering the cost of care, improving healthcare quality, reducing barriers to access, and closing health disparities. This approach leads to more targeted and effective provider engagement strategies and patient support programs.
However, the high cost associated with the drugs, along with spotty reimbursement and sideeffects, could prompt some patients to reconsider a surgical approach whose safety and efficacy are well understood. Device-based treatments for comorbidities associated with obesity will also see an impact.
The absorption, distribution, metabolism, elimination, and mechanism of action of each drug must be considered by all healthcare professionals (HCPs) when deciding the best treatment regimen for their patients, making it a crucial factor in a drugs development and success in the market.
We organize all of the trending information in your field so you don't have to. Join 8,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content